Found: 6
Select item for more details and to access through your institution.
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.
- Published in:
- Nature, 2011, v. 478, n. 7370, p. 529, doi. 10.1038/nature10509
- By:
- Publication type:
- Article
BET Inhibition Silences Expression of <i>MYCN</i> and <i>BCL2</i> and Induces Cytotoxicity in Neuroblastoma Tumor Models.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0072967
- By:
- Publication type:
- Article
Phylogenomics of phosphoinositide lipid kinases: perspectives on the evolution of second messenger signaling and drug discovery.
- Published in:
- BMC Evolutionary Biology, 2011, v. 11, n. 1, p. 1, doi. 10.1186/1471-2148-11-4
- By:
- Publication type:
- Article
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 12, p. 1634, doi. 10.1093/neuonc/noy078
- By:
- Publication type:
- Article
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism.
- Published in:
- Nature Chemical Biology, 2007, v. 3, n. 11, p. 722, doi. 10.1038/nchembio.2007.34
- By:
- Publication type:
- Article